Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Amgen, Zai Lab Team up on DLL3; Janux Gets $35M Milestone Payment

Summary by endpoints.news
Double the DLL3: Amgen and Zai Lab are collaborating on a Phase 1b study that combines the former's T cell engager Imdelltra and the latter's experimental antibody-drug conjugate, known as zocilurtatug pelitecan, in an aggressive ...

3 Articles

The Daily NewsThe Daily News
Reposted by
HealthTech HotSpotHealthTech HotSpot
Center

Zai Lab Announces Global Clinical Trial Collaboration and Supply Agreement to Evaluate Novel DLL3 ADC, Zocilurtatug Pelitecan, in Combination with a Bispecific T-cell Engager Therapy

SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr 1, 2026-

Read Full Article
endpoints.newsendpoints.news

Amgen, Zai Lab team up on DLL3; Janux gets $35M milestone payment

Double the DLL3: Amgen and Zai Lab are collaborating on a Phase 1b study that combines the former's T cell engager Imdelltra and the latter's experimental antibody-drug conjugate, known as zocilurtatug pelitecan, in an aggressive ...

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

The Daily News broke the news in on Wednesday, April 1, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

Amgen icon

Amgen

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal